We are live on ! Find out more
PVI

Pura Vida Investments Portfolio holdings

AUM $14.9M
1-Year Est. Return 38.76%
This Fund
S&P 500
This Quarter Est. Return
+24.68%
1 Year Est. Return
+38.76%
3 Year Est. Return
+26.8%
5 Year Est. Return
+25.03%
10 Year Est. Return
+1,723.84%
AUM
$3.51B
AUM Growth
+$758M
Cap. Flow
+$605M
Cap. Flow %
17.25%
Top 10 Hldgs %
47.4%
Holding
285
New
108
Increased
67
Reduced
35
Closed
69

Top Buys

Rank Stock Value
1
IMDX
Insight Molecular Diagnostics
IMDX
+$28.2M
2
ALGN icon
Align Technology
ALGN
+$19.3M
3
APR
Apria, Inc. Common Stock
APR
+$17.3M
4
CUTR
Cutera, Inc.
CUTR
+$14.8M
5
CMIIU
CM Life Sciences II Inc. Unit
CMIIU
+$13M

Top Sells

Rank Stock Value
1
VCEL icon
Vericel Corp
VCEL
+$14.4M
2
AFIB
Acutus Medical Inc
AFIB
+$13.5M
3
SHC icon
Sotera Health
SHC
+$12.9M
4
OPCH icon
Option Care Health
OPCH
+$12.1M
5
BNGO icon
Bionano Genomics
BNGO
+$10.3M

Sector Composition

Rank Sector Weight
1 Healthcare 33%
2 Industrials 1.49%
3 Materials 0.46%
4 Financials 0.45%
5 Consumer Staples 0.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
IVC
51
DELISTED
Invacare Corporation
IVC
$14.7M 0.42%
1,828,095
+174,154
+11% +$1.62M
QTRX icon
52
Quanterix
QTRX
$133M
$14.1M 0.4%
241,328
+100,153
+71% +$6.77M
CANO
53
DELISTED
Cano Health, Inc.
CANO
$13.9M 0.4%
10,475
+3,525
+51% +$4.99M
SDGR icon
54
Schrodinger
SDGR
$1.4B
$13.8M 0.39%
180,596
+40,596
+29% +$3.65M
PSNL icon
55
Personalis
PSNL
$1.52B
$13.5M 0.38%
548,052
+158,281
+41% +$5.43M
OLK
56
DELISTED
Olink Holding AB (publ) American Depositary Shares
OLK
$13.4M 0.38%
+373,300
New +$12.6M
BVS icon
57
Bioventus
BVS
$1.16B
$13.4M 0.38%
+877,062
New +$12.5M
CMIIU
58
DELISTED
CM Life Sciences II Inc. Unit
CMIIU
$13.3M 0.38%
+1,037,863
New +$13M
SEER icon
59
Seer Inc
SEER
$119M
$13.1M 0.37%
261,923
-31,677
-11% -$1.85M
TXG icon
60
10x Genomics
TXG
$7.43B
$12.8M 0.36%
70,704
+28,204
+66% +$4.87M
DMTK
61
DELISTED
DermTech, Inc. Common Stock
DMTK
$12.5M 0.36%
245,306
-146,772
-37% -$7.68M
MDXG icon
62
MiMedx Group
MDXG
$627M
$11.7M 0.33%
1,136,951
+114,995
+11% +$1.11M
NVST icon
63
Envista
NVST
$4.62B
$11.6M 0.33%
283,176
+98,176
+53% +$3.74M
IART icon
64
PUT
Integra LifeSciences
IART
$1.35B
$11.4M 0.33%
+165,400
New +$11.2M
TPB icon
65
Turning Point Brands
TPB
$1.75B
$11.3M 0.32%
217,543
+53,694
+33% +$2.68M
CDXS icon
66
Codexis
CDXS
$173M
$11M 0.31%
480,935
+95,935
+25% +$2.24M
STXS icon
67
Stereotaxis
STXS
$138M
$10.9M 0.31%
1,626,533
+724,258
+80% +$4.3M
CSTL icon
68
PUT
Castle Biosciences
CSTL
$963M
$10.7M 0.3%
+156,000
New +$11.7M
FLGT icon
69
PUT
Fulgent Genetics
FLGT
$520M
$10.6M 0.3%
+110,000
New +$11.4M
ADPT icon
70
Adaptive Biotechnologies
ADPT
$3.97B
$10.3M 0.29%
256,694
-43,204
-14% -$2.34M
SGFY
71
DELISTED
Signify Health, Inc.
SGFY
$10.1M 0.29%
+345,757
New +$10.7M
MSON
72
DELISTED
Misonix Inc
MSON
$9.89M 0.28%
504,757
+14,171
+3% +$237K
ICUI icon
73
CALL
ICU Medical
ICUI
$4.47B
$9.82M 0.28%
47,800
+20,300
+74% +$4.29M
DXCM icon
74
DexCom
DXCM
$34.2B
$9.61M 0.27%
106,968
+4,236
+4% +$398K
APYX icon
75
Apyx Medical
APYX
$124M
$9.26M 0.26%
958,488
+55,641
+6% +$557K
1 2
3
4 5

Similar funds

BCA
Boundary Creek Advisors New York $15.3M AUM 0.41% 1-Year Est. Return
RC
Raine Capital New York $14.1M AUM 33.16% 1-Year Est. Return
DOFI
DCVC Opportunity Fund II Palo Alto, California $13.9M AUM 8.04% 1-Year Est. Return
SCI
SkyBridge Capital II New York $13.1M AUM 3.36% 1-Year Est. Return
LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return
GBCP
Glade Brook Capital Partners Greenwich, Connecticut $12.8M AUM
SCTC
Samsung C&T Corporation Seoul, South Korea $17.2M AUM 23.45% 1-Year Est. Return
M
MetLife New York $12.3M AUM 29% 1-Year Est. Return

Pura Vida Investments's Q1 2021 Portfolio in Review

As of Q1 2021, Pura Vida Investments held 285 positions worth $3.51B, up 28% from $2.75B the previous quarter. Its ten largest holdings account for 47% of the portfolio.

Pura Vida Investments deployed $605M of net new capital in Q1 2021, opening 108 new positions and adding to 67 existing holdings. Its largest new stake was Align Technology: 35,000 shares worth $19M.

By sector, the portfolio is most concentrated in Healthcare at 33% of assets, down from 34% a quarter earlier, followed by Industrials and Materials.

On the sell side, the largest reduction was Vericel Corp, an estimated $14.4M trimmed.

  • Pura Vida Investments's largest Q1 2021 buy was Align Technology: 35,000 shares worth $19M.
  • Pura Vida Investments added most to Insight Molecular Diagnostics in Q1 2021, an estimated $28.2M increase.
  • Pura Vida Investments's biggest Q1 2021 reduction was Vericel Corp, cutting an estimated $14.4M.
  • Pura Vida Investments fully exited Acutus Medical Inc in Q1 2021, selling an estimated $13.5M.
  • Pura Vida Investments's ten largest holdings make up 47% of its $3.51B portfolio in Q1 2021.
  • Pura Vida Investments opened 108 new positions and closed 69 in Q1 2021.
  • Pura Vida Investments's portfolio value rose 28% quarter-over-quarter to $3.51B.

Based on Pura Vida Investments's 13F filing for Q1 2021, filed 12 May 2021.